Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity

[1]  Fernando A Bozza,et al.  Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis , 2007, Critical care.

[2]  M. Guzmán,et al.  Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever‐dengue shock syndrome (DHF/DSS) , 2007, Immunology and cell biology.

[3]  Trai-Ming Yeh,et al.  MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. , 2006, The Journal of general virology.

[4]  S. Green,et al.  Immunopathological mechanisms in dengue and dengue hemorrhagic fever , 2006, Current opinion in infectious diseases.

[5]  E. Harris,et al.  Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis , 2006, Journal of Virology.

[6]  S. Vasudevan,et al.  Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever , 2006, Reviews in medical virology.

[7]  E. Azeredo,et al.  Activated peripheral lymphocytes with increased expression of cell adhesion molecules and cytotoxic markers are associated with dengue fever disease. , 2006, Memorias do Instituto Oswaldo Cruz.

[8]  Peter B Jahrling,et al.  VIRAL HEMORRHAGIC FEVERS , 1999 .

[9]  E. Azeredo,et al.  NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease , 2006, Clinical and experimental immunology.

[10]  Trai-Ming Yeh,et al.  Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. , 2006, The American journal of tropical medicine and hygiene.

[11]  Angel Balmaseda,et al.  Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. , 2005, The American journal of tropical medicine and hygiene.

[12]  P. Alex,et al.  Multiplex Cytokine Profiling of Initial Therapeutic Response in Patients with Chronic Hepatitis C Virus Infection , 2005, Digestive Diseases and Sciences.

[13]  Eli Schwartz,et al.  Dengue in travelers. , 2005, The New England journal of medicine.

[14]  A. Rothman,et al.  Altered Cytokine Responses of Dengue-Specific CD4+ T Cells to Heterologous Serotypes 1 , 2005, The Journal of Immunology.

[15]  U. Mabalirajan,et al.  Th(2) immune response in patients with dengue during defervescence: preliminary evidence. , 2005, The American journal of tropical medicine and hygiene.

[16]  Allan Hildesheim,et al.  HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. , 2005, Vaccine.

[17]  G. Coelho,et al.  Dengue and Dengue Hemorrhagic Fever, Brazil, 1981–2002 , 2005, Emerging infectious diseases.

[18]  S. Lemon,et al.  Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees , 2004, Journal of Virology.

[19]  S. Um,et al.  Systemic host inflammatory and coagulation response in the Dengue virus primo-infection. , 2004, Cytokine.

[20]  Demosthenes Bouros,et al.  The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome , 2004, BMC pulmonary medicine.

[21]  I. Meza,et al.  IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. , 2004, The Journal of general virology.

[22]  R. Kroczek,et al.  Coordinate Expression of Cytokines and Chemokines by NK Cells during Murine Cytomegalovirus Infection1 , 2004, The Journal of Immunology.

[23]  Tom Solomon,et al.  Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful? , 2004, The American journal of tropical medicine and hygiene.

[24]  S. Halstead,et al.  Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. , 2004, The Journal of infectious diseases.

[25]  M. Datta,et al.  Predictors of spontaneous bleeding in Dengue , 2004, Indian journal of pediatrics.

[26]  M. Guzmán,et al.  Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[27]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[28]  J. Van Damme,et al.  Macrophage inflammatory protein-1. , 2002, Cytokine & growth factor reviews.

[29]  Yun-Chi Chen,et al.  Activation of Terminally Differentiated Human Monocytes/Macrophages by Dengue Virus: Productive Infection, Hierarchical Production of Innate Cytokines and Chemokines, and the Synergistic Effect of Lipopolysaccharide , 2002, Journal of Virology.

[30]  A. Nisalak,et al.  Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. , 2002, The Journal of infectious diseases.

[31]  A. Nisalak,et al.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. , 2002, The Journal of infectious diseases.

[32]  D. Gubler.  Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. , 2002, Trends in microbiology.

[33]  J. V. D. van der Meer,et al.  The Role of Cytokines in Activation of Coagulation and Fibrinolysis in Dengue Shock Syndrome , 2002, Thrombosis and Haemostasis.

[34]  T. Ksiazek,et al.  Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (reston serotype) * * , 2001, Journal of medical virology.

[35]  E L Braga,et al.  Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. , 2001, Memorias do Instituto Oswaldo Cruz.

[36]  E. Azeredo,et al.  Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. , 2001, Immunobiology.

[37]  E. Harris,et al.  Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. , 2000, The American journal of tropical medicine and hygiene.

[38]  H. Schatzmayr,et al.  Evaluation of an IgG enzyme-linked immunosorbent assay for dengue diagnosis. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[39]  A. Nisalak,et al.  Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. , 1999, The Journal of infectious diseases.

[40]  E. Chungue,et al.  Plasma levels of tumour necrosis factor a and transforming growth factor β-1 in children with dengue 2 virus infection in French Polynesia , 1998 .

[41]  Duane J. Gubler,et al.  Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.

[42]  D. Kwiatkowski,et al.  Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. , 1998, The Journal of infectious diseases.

[43]  E. Chungue,et al.  Plasma levels of tumour necrosis factor alpha and transforming growth factor beta-1 in children with dengue 2 virus infection in French Polynesia. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[44]  H. Schatzmayr,et al.  Diagnosis of dengue by using reverse transcriptase-polymerase chain reaction. , 1997, Memorias do Instituto Oswaldo Cruz.

[45]  M. Baggiolini,et al.  Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. , 1996, Journal of immunology.

[46]  D. Taub,et al.  Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. , 1995, Journal of immunology.

[47]  P. Allavena,et al.  Effects of granulocyte‐monocyte colony‐stimulating factor (GM‐CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer‐associated macrophages , 1995, International journal of cancer.

[48]  D. Hober,et al.  Serum Levels of Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1β (IL-1β) in Dengue-Infected Patients , 1993 .

[49]  A. Nisalak,et al.  High levels of interferon alpha in the sera of children with dengue virus infection. , 1993, The American journal of tropical medicine and hygiene.

[50]  H. Schatzmayr,et al.  Dengue epidemic in the state of Rio de Janeiro, Brazil: virological and epidemiological aspects. , 1993, Revista do Instituto de Medicina Tropical de Sao Paulo.

[51]  D. Hober,et al.  Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. , 1993, The American journal of tropical medicine and hygiene.

[52]  A. Nisalak,et al.  Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. , 1991, The Journal of clinical investigation.

[53]  T. Vitarana,et al.  Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. , 1991, The Ceylon medical journal.